Teva settles price fixing charges with u.s. doj

Tel aviv, israel & parsippany, n.j.--(business wire)--teva pharmaceuticals, a u.s. affiliate of teva pharmaceutical industries ltd. (nyse and tase: teva), has reached a deferred prosecution agreement (dpa) with the u.s. department of justice (doj) to settle the criminal price-fixing charges brought against teva in 2020. under the dpa, which will allow teva to avoid mandatory exclusion from participation in u.s. federal health care programs, teva will pay a fine of $225 million over five years,.
TEVA Ratings Summary
TEVA Quant Ranking